Survival of patients operated for stage I non-small-cell lung cancer Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Early metastases in surgically treated NSCLC patients Source: Eur Respir J 2003; 22: Suppl. 45, 254s Year: 2003
Survival and recurrences following surgical treatment of N2 NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006
Survival of elderly small-cell lung cancer patients Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010
The survival in elderly patients after resection of lung cancer Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
Survival after induction chemotherapy and surgery in N2 (mediastinoscopy) NSCLC patients Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Disease relapse in surgically and conservatively treated patients with stage I-II of non-small cell lung cancer Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010
Survival of patients after complete surgical resection in NSCLC stage IV with solitary metastases Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Our operated lung cancer cases and their survival results Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002
Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
The expression of Bcl-xl correlates with improved survival in chemo-naive, surgically resected NSCLC patients Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
Importance of CYFRA-21 in estimation of survival of patients with NSCLC Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006
Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013
Comorbidity in lung cancer – operated patients. Impact on survival and prognosis Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005
Treatment tolerance and survival in elderly patients with stage IV non-small cell lung cancer (NSCLC) Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Factors predicting complete surgical resection after induction chemotherapy in patients with initially unresectable non-small cell lung cancer (NSCLC) treated in a randomised trial Source: Eur Respir J 2003; 22: Suppl. 45, 162s Year: 2003
Clinical and biological predictors of progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced non-small-cell lung cancer (NSCLC) treated by erlotinib in the ERMETIC cohort Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010
Time trends in long term survival of patients operated for primary NSCLC Source: Eur Respir J 2004; 24: Suppl. 48, 41s Year: 2004
Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019